Rebuttal: PTH-a particularly tricky hormone: Why measure it at all in kidney patients?

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 2, 2013, Pages 321-

  Sprague, Stuart M ^a   Moe, Sharon M ^b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; PARATHYROID HORMONE;

ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL DECISION MAKING; HUMAN; HYPERPARATHYROIDISM; KIDNEY DISEASE; MORBIDITY; MORTALITY; STANDARDIZATION;

HUMANS; PARATHYROID HORMONE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84875013912     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10331012     Document Type: Article

References (5)

1. Garrett G, Sardiwal S, Lamb EJ, Goldsmith DJA: PTH-a particularly tricky hormone: why measure it at all in kidney patients? Clin J Am Soc Nephrol 7: 000-000, 2012.
2. KDIGO: Clinical Practice Guidelines for the Management of CKD-MBD. Kidney Int 76: S1-S130, 2009
3. Zidehsarai MP, Moe SM: Review article: Chronic kidney disease-mineral bone disorder: Havewe got the assays right? Nephrology (Carlton) 14: 374-382, 2009
4. Malluche HH, Bellorin-Font ER, Rojas E, Carvalho AB, D'Haese PC, Drueke TB, Ferreira MA, Jorgetti V, Moe SM, Sprague SM: Predictive value of biomarkers for bone turnover in ESKD. Presented at Renal Week 2010, Denver, Colorado, November 16-21, 2010
5. Massry SG, Smogorzewski M: Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia. Semin Nephrol 14: 219-231, 1994